Caricamento...
Antiproliferative effects of masitinib and imatinib against canine oral fibrosarcoma in vitro
BACKGROUND: Canine oral fibrosarcoma (COF) is one of the most common oral tumors in dogs and carries a guarded prognosis due to a lack of effective systemic therapeutic options. Mastinib and imatinib are two commonly used tyrosine kinase inhibitors (TKIs) in veterinary oncology but their potential e...
Salvato in:
| Pubblicato in: | BMC Vet Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4893279/ https://ncbi.nlm.nih.gov/pubmed/27259510 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12917-016-0712-x |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|